SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Huc Jean-Francois

(Last)

(First)

(Middle)

C/O BIOAMBER INC.

1250 RENE LEVESQUE WEST, SUITE 4110

(Street)

MONTREAL

H3B 4W8

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/09/2013

3. Issuer Name and Ticker or Trading Symbol
BioAmber Inc. [ BIOAU ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,345	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	12/08/2011	12/08/2018	Common Stock	77,000	$1.072	D
Stock Option (right to buy)	04/17/2012	04/17/2019	Common Stock	24,500	$1.072	D
Stock Option (right to buy)	⁽¹⁾	07/21/2020	Common Stock	70,000	$5.743	D
Stock Option (right to buy)	⁽²⁾	06/27/2021	Common Stock	213,500	$10.547	D
Warrants (right to buy)	04/17/2009	05/01/2017	Common Stock	52,500	$1.072	D
Warrants (right to buy)	04/17/2009	05/01/2017	Common Stock	38,500	$1.072	D
Warrants (right to buy)	02/06/2009	02/06/2019	Common Stock	154,700	$1.429	D
Warrants (right to buy)	04/15/2011	04/15/2021	Common Stock	595	$10.547	D

Explanation of Responses:

1. The stock option shall vest over a four year period beginning on July 21, 2010, in reason of 25% per year (prorated monthly). All of the stock options become fully vested and exercisable upon completion of the Issuer's initial public offering.

2. 25% of the stock option vested on June 27, 2012 and the remaining 75% of the shares vest on a monthly basis over the following three years.

	/s/ Jean-Francois Huc	05/09/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.